Cita APA (7a ed.)

Haines, E., Nishida, Y., Carr, M. I., Montoya, R. H., Ostermann, L. B., Zhang, W., . . . Vassilev, L. T. (2021). DNA-PK inhibitor peposertib enhances p53-dependent cytotoxicity of DNA double-strand break inducing therapy in acute leukemia. Nature Portfolio.

Cita Chicago Style (17a ed.)

Haines, Eric, et al. DNA-PK Inhibitor Peposertib Enhances P53-dependent Cytotoxicity of DNA Double-strand Break Inducing Therapy in Acute Leukemia. Nature Portfolio, 2021.

Cita MLA (8a ed.)

Haines, Eric, et al. DNA-PK Inhibitor Peposertib Enhances P53-dependent Cytotoxicity of DNA Double-strand Break Inducing Therapy in Acute Leukemia. Nature Portfolio, 2021.